Supplemental Table 2 from Discovery and Pharmacological Characterization of JNJ-42756493 (erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor

Timothy P.S. Perera, Eleonora Jovcheva,Laurence Mevellec,Jorge Vialard,Desiree De Lange,Tinne Verhulst, Caroline Paulussen, Kelly Van De Ven,Peter King,Eddy Freyne, David C. Rees,Matthew Squires,Gordon Saxty,Martin Page,Christopher W. Murray, Ron Gilissen,George Ward,Neil T. Thompson,David R. Newell,Na Cheng,Liang Xie,Jennifer Yang,Suso J. Platero,Jayaprakash D. Karkera,Christopher Moy,Patrick Angibaud,Sylvie Laquerre,Matthew V. Lorenzi

openalex（2023）

引用 0|浏览0

暂无评分

摘要

Inhibitory activity of Brivanib and JNJ-42756943 in kinase (top) and BaF3 kinase dependent proliferation (bottom) assays and ratio of FGFRs/VEGFR2 activities.

查看译文

关键词

Fibroblast Growth Factor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要